Dhana Sekhar Reddy Bandi

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress”.

UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress

NAR Cancer(2022)10.1093/narcan/zcac035

N/A

0.477DataRank · unranked

23 citations

Praveen Guruvaiah, Kiran Kumar Reddi, Suresh Bugide, Dhana Sekhar Reddy Bandi, Yvonne J. K. Edwards +3 more

A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer

Cancer Research(2024)10.1158/0008-5472.can-24-0323

N/A

0DataRank · unranked

22 citations

Tyler Mattox, Adam B. Keeton, Xi Chen, Forrest Smith, Kristy Berry +30 more

ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

Molecular Cancer(2025)10.1186/s12943-025-02288-9

N/A

0DataRank · unranked

17 citations

Ganji Purnachandra Nagaraju, Sujith Sarvesh, Julienne L. Carstens, Jeremy B. Foote, Emily C. Graff +17 more